Image

Exercise and physical activity are important to deal with the fatigue that may come from scleroderma. Too little activity can make fatigue worse. According to the US National Library of Medicine National Institutes of Health, scleredema diabeticorum is characterized by a dramatic increase in the thickness of the skin…

Cytori Therapeutics recently announced that its Phase 3 STAR clinical trial, evaluating the efficacy and safety of Cytori Cell Therapy in scleroderma patients with hand impairment, has treated its 20th patient to reach 25 percent of its enrollment and treatment goal. The trial is continuing on the recommendation of an independent monitoring committee that evaluated safety data…

https://sclerodermanews.com/wp-content/uploads/videos/Sequence05.mp4 Scleroderma News correspondent Dr. Ana de Barros conducts an exclusive interview with Adi Mor from ChemomAb. See our live coverage of #SSc16 on Twitter and here: http://bit.ly/1Ts2X9H…

In this video by the Arthritis National Research Foundation, meet Anne Stevens, MD, PhD, who is one of the world’s leading researchers in scleroderma and lupus research. Her autoimmune research is paving the way for new treatments for patients with scleroderma, lupus and related autoimmune diseases.

Last week’s hot topic on Scleroderma was Pulmonary Hypertension Prevented, Treated by Macitentan in Systemic Sclerosis Mouse Model written by Magdalena Kegel. This article is about a study which showed that macitentan (Opsumit) can prevent pulmonary arterial hypertension (PAH) in a mouse model of…

https://sclerodermanews.com/wp-content/uploads/videos/activadanone.mp4 Scleroderma News correspondent Dr. Ana de Barros conducts an exclusive interview with Pierre Broqua and Yannick Allanore from Inventiva. Follow our live coverage of #SSc16 on Twitter and here: http://bit.ly/1Ts2X9H  …

https://sclerodermanews.com/wp-content/uploads/videos/Sequence04.mp4 Scleroderma News correspondent Dr. Ana de Barros conducts an exclusive interview with Dr. Mihaela Ianosev, GlaxoSmithKline. Follow our live coverage of #SSc16 on Twitter and here: http://bit.ly/1Ts2X9H…

https://sclerodermanews.com/wp-content/uploads/videos/Entrevista02.mp4 Scleroderma News correspondent Dr. Ana de Barros conducts an exclusive interview with Dr. Colin Meyer, Reata Pharmaceuticals. Follow our live coverage of #SSc16 on Twitter and here: http://bit.ly/1Ts2X9H…

https://sclerodermanews.com/wp-content/uploads/videos/Sequence%2001_1.mp4 Scleroderma News correspondent Dr. Ana de Barros has conducted an exclusive interview with Prof. Christopher Denton, the lead investigator in a Bayer’s clinical trial, at the 4th Systemic Sclerosis World Congress, currently underway in Lisbon, Portugal. Stay tuned for a feature article and complete interview.

The 4th Systemic Sclerosis World Congress, organized by the World Scleroderma Foundation (WSF), will run Feb. 18–20 at the Lisbon Congress Center in Lisbon, Portugal, and Scleroderma News Today will be there to cover and report on the proceedings Experts with…